Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Raman spectroscopic signatures of amyloid fibrils: Insights into structural and biochemical changes in human tissues.

Biophysical chemistry·2025
Same author

Supramolecular arrangements in human amyloid tissues using SAXS.

Biophysical chemistry·2024
Same author

Epithelial-mesenchymal transition profiles in triple negative breast carcinoma may explain its aggressive nature.

The Malaysian journal of pathology·2023
Same author

Gastrointestinal stromal tumour in a jejunal diverticulum: The eighth reported case worldwide with a brief review of the literature.

The Malaysian journal of pathology·2023
Same author

EDXRF and the relative presence of K, Ca, Fe and as in amyloidogenic tissues.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2023
Same author

A review: Exploring the metabolic and structural characterisation of beta pleated amyloid fibril in human tissue using Raman spectrometry and SAXS.

Progress in biophysics and molecular biology·2023

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Cytokeratin immunoreactivity in Ewing sarcoma/ primitive neuroectodermal tumour.

S H A Elbashier1, A R Nazarina, L M Looi

  • 1University Malaya, Faculty of Medicine, Pathology Department, Jalan Universiti, 50603 Kuala Lumpur, Malaysia.

The Malaysian Journal of Pathology
|December 24, 2013
PubMed
Summary

Cytokeratin expression is present in nearly 40% of Ewing sarcoma (ES)/primitive neuroectodermal tumors (PNET) in Malaysian patients. This finding supports epithelial differentiation and is crucial for diagnosing small round cell tumors.

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

Area of Science:

  • Oncology
  • Pathology
  • Immunohistochemistry

Background:

  • Ewing sarcoma (ES)/primitive neuroectodermal tumor (PNET) is an aggressive small round cell tumor primarily affecting young individuals.
  • Cytokeratin expression in ES/PNET has been reported sporadically, necessitating further investigation.

Purpose of the Study:

  • To investigate the prevalence and patterns of cytokeratin expression in Malaysian patients diagnosed with ES/PNET.
  • To determine the association of cytokeratin expression with clinical and pathological parameters.

Main Methods:

  • Immunohistochemical staining for cytokeratin markers AE1/AE3 and MNF116 was performed on 43 ES/PNET cases.
  • Analysis of cytokeratin expression patterns (focal, intermediate, diffuse).
  • Correlation of cytokeratin immunoreactivity with patient age, sex, tumor location, stage, and treatment status.

Main Results:

  • Cytokeratin expression was observed in 17 out of 43 cases (39.5%) of ES/PNET.
  • No significant association was found between cytokeratin expression and patient demographics, tumor site, or disease status.
  • A significant association was demonstrated between cytokeratin expression and neuron-specific enolase (NSE) expression.

Conclusions:

  • The study provides evidence supporting epithelial differentiation in a subset of ES/PNET.
  • Cytokeratin expression should not exclude ES/PNET from the differential diagnosis of small round cell tumors.
  • Immunohistochemical findings aid in the diagnostic workup of challenging small round cell neoplasms.